KRKA
European generics pharmaceutical company with integrated capabilities across discovery, development, production and distribution of prescription, over-the-counter and veterinary medicines. Operates research and development laboratories, analytical and quality-control facilities, clinical research activities (including post‑marketing studies), and vertically integrated manufacturing and supply‑chain operations to support global product registration and distribution.
Industries
N/A
Nr. of Employees
small (1-50)
Products
Herbal‑extract throat lozenges
Hard lozenges formulated with a dry herbal extract intended to hydrate and protect oral and pharyngeal mucosa and relieve hoarseness and dry cough in users aged 12 and over.
Surface disinfectant (Ecocid S)
Broad‑spectrum surface disinfectant and hygiene product manufactured for rapid surface decontamination and infection‑control use.
Herbal‑extract throat lozenges
Hard lozenges formulated with a dry herbal extract intended to hydrate and protect oral and pharyngeal mucosa and relieve hoarseness and dry cough in users aged 12 and over.
Surface disinfectant (Ecocid S)
Broad‑spectrum surface disinfectant and hygiene product manufactured for rapid surface decontamination and infection‑control use.
Services
Design and execution of clinical studies including post‑marketing evaluations to assess safety and efficacy.
Formulation development, analytical testing and GMP production of human and veterinary medicines, with integrated quality systems.
Digital podcasts, articles and learning resources for healthcare professionals to disseminate clinical knowledge and best practices.
Development and operation of clinician‑facing and consumer web applications for information, risk calculation and product support.
Manufacture and distribution of surface disinfectants and hygiene formulations for healthcare and public‑health use, including emergency supply coordination.
Design and execution of clinical studies including post‑marketing evaluations to assess safety and efficacy.
Formulation development, analytical testing and GMP production of human and veterinary medicines, with integrated quality systems.
Digital podcasts, articles and learning resources for healthcare professionals to disseminate clinical knowledge and best practices.
Development and operation of clinician‑facing and consumer web applications for information, risk calculation and product support.
Manufacture and distribution of surface disinfectants and hygiene formulations for healthcare and public‑health use, including emergency supply coordination.
Expertise Areas
- Generic pharmaceutical development and manufacturing
- Formulation development for solid and liquid dosage forms (including extended‑release and bilayer technologies)
- Clinical research and post‑marketing surveillance
- Analytical chemistry and laboratory quality control
Key Technologies
- GMP manufacturing
- API synthesis and process development
- Extended‑release formulation technologies
- Bilayer tablet technology
News & Updates
Donation and supply of disinfectant volumes to support national emergency response during the COVID‑19 pandemic.
Announcement offering summer work opportunities for pupils and students to gain practical experience.
Proposal to pay a gross dividend of EUR 9.10 per share, 10.3% increase year over year.
Corporate films received international awards at the FilmAT festival.
Received an independent S&P Global CSA sustainability rating score of 55 out of 100.
Donation and supply of disinfectant volumes to support national emergency response during the COVID‑19 pandemic.
Announcement offering summer work opportunities for pupils and students to gain practical experience.
Proposal to pay a gross dividend of EUR 9.10 per share, 10.3% increase year over year.
Corporate films received international awards at the FilmAT festival.
Received an independent S&P Global CSA sustainability rating score of 55 out of 100.